Latest News

Mutant-Allele Tumor Heterogeneity (MATH) in head, neck squamous cell carcinoma patients is effective marker, along with HPV status, of improved patient outcome

Evaluating next-generation sequencing (NGS) data and associated clinical records of head and neck squamous cell carcinoma (HNSCC) patients from several institutions, made available through The Cancer Genome Atlas (TCGA), showed that combining Mutant-Allele Tumor Heterogeneity (MATH) as a biomarker with the patient?s HPV status provides an effective indicator of improved patient outcome, according to research.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Optogenetic stimulation of the brain to control pain demonstrated in study

  • Emergency doctors and paramedics commonly misinterpret documents for end-of-life care choices, study finds

  • Twin study lends new insights into link between back pain and depression

  • Persistent Insomnia, Increased Mortality Risk: Link found by researchers

  • Thinking of God makes people bigger risk-takers, study suggests

  • Teacher prejudices put girls off math, science, study suggests

  • Moffitt researchers identify protein pathway involved in brain tumor stem cell growth

  • Bumblebees make false memories too

  • Neurons that help predict what another individual will do identified

  • Method for mapping neuron clusters developed

  •